Mynvax Profile
Key Indicators
- Authorised Capital ₹ 1.30 M
as on 26-07-2024
- Paid Up Capital ₹ 0.59 M
as on 26-07-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 89.38%
(FY 2023)
- Profit 20.95%
(FY 2023)
- Ebitda -38.83%
(FY 2023)
- Net Worth -17.17%
(FY 2023)
- Total Assets -29.92%
(FY 2023)
About Mynvax
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.30 M and a paid-up capital of Rs 0.59 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Mynvax Private Limited India is Hurukadli Virupakshappa as COMPANY SECRETARY. Gautham Nadig, Mahendran Balachandran, Arun Chandavarkar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U73200KA2017PTC102838
- Company No.
102838
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 May 2017
- Date of AGM
30 Jun 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Mynvax?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hurukadli Virupakshappa | Company Secretary | 12-Jan-2023 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahendran Balachandran  | Nominee Director | 07-Aug-2021 | Current |
| Gautham Nadig | Director | 05-May-2017 | Current |
| Arun Chandavarkar | Director | 01-Jan-2021 | Current |
| Anil Gudibande | Director | 16-Oct-2019 | Current |
Ganesh Kishore  | Director | 29-Dec-2017 | Current |
| Raghavan Varadarajan | Director | 05-May-2017 | Current |
Financial Performance and Corporate Structure Insights of Mynvax.
Mynvax Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 89.38% increase. The company also saw a substantial improvement in profitability, with a 20.95% increase in profit. The company's net worth observed a substantial decline by a decrease of 17.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mynvax?
In 2023, Mynvax had a promoter holding of 32.25% and a public holding of 67.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Probe Information Services Private Limited
Active 19 years 6 monthsMahendran Balachandran is a mutual person
Insorce Operational Optimizers Private Limited
Active 17 years 27 daysAnil Gudibande is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mynvax?
Mynvax has a workforce of 26 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mynvax, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mynvax's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
